Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2003
11/27/2003US20030219419 Alteration of cell membrane for new functions
11/27/2003US20030219405 Oral administration of interferon-tau
11/27/2003US20030219404 A therapeutic polypeptide drug conjugated with two chains of polyoxyethylene glycol, linked to a cyclohexane ring; high molecular weight, stability, nontoxic, sustained release
11/27/2003US20030219402 Drug delivery of a fusion protein comprising plurality of component molecules linked with a linker, containing an enzyme cleavage site to be cleaved by an enzyme in a treated subject
11/27/2003US20030219398 A copolymer comprising acryloyldimethyltauric acid and vinyl pyrrolidone and crosslinking monomer allyl acrylate or methacrylate monomers; oil emulsions or water in oil emulsions for cosmetic and drug use
11/27/2003US20030219392 Composition to enhance permeation of topical skin agents
11/27/2003US20030219383 Intramolecularly-quenched near infrared fluorescent probes
11/27/2003US20030219379 Antiproliferative agent
11/27/2003US20030219378 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
11/27/2003US20030219375 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
11/27/2003US20030219354 Deactivation pathogens; using riboflavin sensitizers; exposure to light source
11/27/2003US20030217908 Method and apparatus for transferring substrates
11/27/2003CA2752143A1 Delivery of nucleic acid-like compounds
11/27/2003CA2486635A1 Drug delivery assembly
11/27/2003CA2486468A1 Improvements in delivery technology
11/27/2003CA2486461A1 Powder compaction and enrobing
11/27/2003CA2486307A1 Drug pre-targeting by means of bi-specific antibodies and hapten constructs comprising a carrier peptide and the active agent(s)
11/27/2003CA2486133A1 Injection formulation
11/27/2003CA2486127A1 Method of treating dyslipidemic disorders
11/27/2003CA2485463A1 A direct cellular energy delivery system
11/27/2003CA2485399A1 Co-grinding process for the preparation of a ternary composition
11/27/2003CA2485006A1 Camptothecin derivatives and polymeric conjugates thereof
11/27/2003CA2484512A1 Treatment of cataracts and other ophthalmic diseases
11/27/2003CA2482458A1 Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier
11/27/2003CA2471879A1 Pharmaceutical composition containing ghrelin
11/26/2003EP1364967A2 Glucagon-like insulinotropic peptides, compositions and methods
11/26/2003EP1364660A1 Drug-releasing system of biodegradable polymer type
11/26/2003EP1364656A2 Use of bone morphogenetic proteins for healing and repair of connective tissue attachment
11/26/2003EP1364654A1 Eye drops
11/26/2003EP1364651A1 Pharmaceutical composition with deswelling properties
11/26/2003EP1364646A1 Fenofibrate-containing composition
11/26/2003EP1364642A1 Composition for delivery of dithranol
11/26/2003EP1364208A2 Conjugates of defined stoichiometry
11/26/2003EP1364019A2 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins)
11/26/2003EP1363996A2 Epothilone resistant cell lines
11/26/2003EP1363964A1 Polymer comprising water-soluble units and lcst units and aqueous composition containing same
11/26/2003EP1363951A2 Polynuclear complex fe(iii) with pullulan oligomers, process of its obtaining, and pharmaceutical preparations on the basis of the complex
11/26/2003EP1363933A2 Sterol derivatives, liposomes comprising sterol derivatives and method for loading liposomes with active substances
11/26/2003EP1363932A2 Amphoteric sterols and the use thereof
11/26/2003EP1363890A2 Melanocortin-4 receptor binding compounds and methods of use thereof
11/26/2003EP1363730A1 Process for making microcapsules involving phase inversion
11/26/2003EP1363676A2 Method of enhancing delivery of a therapeutic nucleic acid
11/26/2003EP1363675A2 Compositions useful in gene therapy
11/26/2003EP1363674A2 Agents and methods for treating pain
11/26/2003EP1363673A2 Compositions for reducing side effects in chemotherapeutic treatments
11/26/2003EP1363672A1 Carrier systems comprising vitamin b12 - biodegradable micro particulate conju gates for peroral delivery of drugs, peptides/proteins and vaccines
11/26/2003EP1363671A2 Water-soluble compositions of bioactive lipophilic compounds
11/26/2003EP1363670A1 Polynucleotide formulation for enhanced intracellular transfer
11/26/2003EP1363668A2 Combinations of bile acid sequestrant(s) and sterol absorption inhibitor(s) and treatments for vascular indications
11/26/2003EP1363664A2 Synthetic vaccine agents
11/26/2003EP1363637A1 Pyrimidine compounds and methods for making and using the same
11/26/2003EP1363626A1 Antifungal remedy formulation for external application
11/26/2003EP1363622A1 Pharmaceutical compositions including sampatrilat dispersed in a lipoidic vehicle
11/26/2003EP1363617A1 Cyanoacrylate compositions for prophylactic or therapeutic treatment of diseases manifesting themselves in and/or damaging cutaneous tissue
11/26/2003EP1363608A1 Treatment of sleep disturbances
11/26/2003EP1363607A2 Pharmaceutical formulation
11/26/2003EP1363604A2 Pharmaceutical formulation
11/26/2003EP1363602A1 Local anesthetic, and method of use
11/26/2003EP1363601A2 Amphoteric liposomes and the use thereof
11/26/2003EP1363600A1 Liquid formulations for the prevention and treatment of mucosal diseases and disorders
11/26/2003EP1363585A2 Cosmetic or pharmaceutical agent
11/26/2003EP1363583A2 Cosmetic and/or pharmaceutical agents containing an acylated amino acid and protein condensate
11/26/2003EP1363556A2 Novel in-situ forming controlled release microcarrier delivery system
11/26/2003EP1363508A1 Emulsions and aqueous dispersions of phytosterols
11/26/2003EP1301196B1 Stimulation of bone growth with thrombin peptide derivatives
11/26/2003EP1227877B1 Polydisperse double emulsion, corresponding monodisperse double emulsion and method for preparing the monodisperse emulsion
11/26/2003EP1202982B1 Method for preparing a gamma-unsaturated beta-lactone and use thereof as an aromatic and flavouring ingredient
11/26/2003EP1176982B1 Prucalopride oral solution
11/26/2003EP1158859B1 Iodine preparation compositon
11/26/2003EP1140034B1 Controlled release formulation of divalproex sodium
11/26/2003EP1124541B1 Application of water-soluble or water-dispersible graft polymerizates which contain poly-ether and which are used as a coating agent, a binding agent and/or as a film-forming auxiliary agent in pharmaceutical forms of administration
11/26/2003EP1086706B1 Stabilized compositions containing nootropic drugs
11/26/2003EP1037614B1 A double capsule for the administration of active principles in multiple therapies
11/26/2003EP0871492B1 Mesothelium antigen and methods and kits for targeting it
11/26/2003EP0814843B1 Hapten-carrier conjugates for use in drug-abuse therapy
11/26/2003EP0721478B1 Pyrrolidone-group-containing polyesters and polyamides
11/26/2003CN1458977A Fusion protein from antibody cytokine-cytokine inhibitor (selectokine) for use as target-specific prodrug
11/26/2003CN1458974A Stimulation of cartilage growth with agonists of non-protecolytically activated thrombin receptor
11/26/2003CN1458935A Integrain binding motif containing peptides and methods of treating skeletal diseases
11/26/2003CN1458926A Nitric oxide donors based on metallic centres
11/26/2003CN1458846A Synthetic erythropoiesis stimulating protein
11/26/2003CN1458845A Pharmaceutical composition comprising condensed indole compound
11/26/2003CN1458840A Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
11/26/2003CN1457886A Process for preparing poly lactic acid super microball carrying medicine
11/26/2003CN1457785A Doxazosin mesilate slow releasing preparation
11/26/2003CN1457781A Cetirizing hydrochloride cataplasm preparation
11/26/2003CN1457766A Mucilage antiseptic medicine composition capable of being locally administratied and sustainably released and its preparing method
11/26/2003CN1457765A Cetirizine hydrochloride gel
11/26/2003CN1128619C Utilization of powder prepns. contg. hydroxypyridones treating leg ulcer and decubitus ulcers
11/26/2003CN1128618C Use of histamine for elevating blood histamine
11/26/2003CN1128616C Use of water-free lactose in producing solid mixtures containing nitroglycerine
11/26/2003CN1128614C Use of dichlorobenzyl alcohol for preparing a preparation for topical treatment of inflammation and preparation containing it
11/26/2003CN1128612C Pharmaceutical composition with base of rhein or diacerhein with improved biological availability
11/25/2003US6653505 Oxidation resistance
11/25/2003US6653458 Modified oligonucleotides
11/25/2003US6653427 Introducing monomeric 2-hydroxyethyl methacrylate containing ethylene glycol dimethacrylate impurities in the range of 0.05 to 0.1% by weight with hydroxybutyl acrylate into a solution of water and alcohol, copolymerizing; gel-free
11/25/2003US6653334 Benzoxazole compound and pharmaceutical composition containing the same
11/25/2003US6653329 Granulated pharmaceutical formulations and methods for making the same
11/25/2003US6653295 Protease inhibitor; viricide
11/25/2003US6653292 Stimulating Th1 pattern of immune activation, cytokine production, NK lytic activity and B cell proliferation; modulating with nucleic acid sequences containing unmethylated CpG dinucleotides
1 ... 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 ... 1712